Hippocratic AI

Hippocratic AI develops generative AI agents, delivered largely as clinical voice agents, for non-diagnostic, patient-facing healthcare tasks. Its agents are used by providers, payors and life sciences/pharma organizations for work such as patient intake screening, appointment scheduling, annual wellness visit outreach, chronic care and case management, post-discharge and post-surgical follow-up, medication adherence and reconciliation, cancer screening outreach (colorectal, mammogram), eligibility and benefits confirmation, health risk assessments, patient assistance program enrollment, adverse event documentation, clinical trial pre-screening and real-world-evidence longitudinal follow-up. The company states explicitly that its agents do not diagnose or prescribe and escalate to human nurses when validated nurse guidelines indicate it is necessary [0][1][6].

The company was founded in 2023 by generative AI researchers, physicians, hospital administrators and Medicare experts, with team members drawn from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google and Nvidia. Its first commercial product, a task-specific generative AI healthcare agent, was released in June 2024. It markets a catalog of over 1,000 AI healthcare agents organized by care setting (provider, payor, pharma), medical specialty and organizational goal [0][1][6][7].

By November 2025 the company reported more than 50 enterprise health system, payor and pharma partners across six countries, over 1,000 clinical use cases, and over 115 million clinical patient interactions with no reported safety issues; its own website cites 250M+ patient interactions, 300+ live clinical use cases, 50+ EMR integrations including Epic, and 31,000+ patients escalated to nursing care [0][1][4][6]. It is headquartered in Palo Alto, California [4].

Founding story

CEO Munjal Shah, previously co-founder of Andale (1999), Like.com (acquired by Google) and Health IQ (2013), founded Hippocratic AI in 2023 after concluding that generative AI could address healthcare cost, outcome and workforce-shortage problems. The company was founded by a group of generative AI researchers, physicians, hospital administrators and Medicare experts, including people from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google and Nvidia. General Catalyst describes itself as having co-created the company [4][6][7].

Business model

Enterprise B2B: Hippocratic AI contracts with health systems, payors and pharmaceutical/life sciences companies to deploy its AI agents against defined clinical and administrative use cases, integrating with electronic medical record systems (50+ integrations, including Epic). The company states that its contracts take on liability for agent performance [0][1][4][6].

Traction

As of the November 2025 Series C announcement: partnerships with more than 50 large health systems, payors and pharma clients across six countries; over 1,000 clinical use cases built; and more than 115 million clinical patient interactions with no safety issues, achieved in the 15 months since commercialization. The company's website cites 250M+ patient interactions, zero incidents of harm since inception, 31,000+ appropriate escalations to nursing care, 300+ clinical use cases live, and 50+ EMR integrations. Named customers include Cleveland Clinic, Northwestern Medicine, Ochsner Health, Moffitt Cancer Center, University Hospitals, Guy's & St Thomas' NHS Trust, Advocate Health, Cincinnati Children's Hospital, Sanford Health, OhioHealth, Memorial Hermann, Eucalia, VNS Health, WellSpan Health, Sheba Medical Center, Universal Health Services, Cleveland Clinic Abu Dhabi, HonorHealth, Burjeel, Medical Mutual, Fraser Health, Leidos and LeanTaaS [0][1][4][6].

Latest developments

On November 3, 2025 the company announced a $126 million Series C at a $3.5 billion valuation led by Avenir Growth, to fund broader and deeper worldwide customer deployments, continued investment in its Polaris Safety Constellation Architecture, product innovation, and strategic M&A; CEO Munjal Shah said acquisition targets would not be competitors in the healthcare AI market. Recent operational moves include selecting Fivetran for its data foundation, a partnership with Eraas Health to integrate environmental analytics into preventive care workflows, deployment of voice agents for non-diagnostic patient support with University Hospitals, and completion of a SOC 2 Type II audit [4][5][6].